Accueil>>Signaling Pathways>> Proteases>> E1/E2/E3 Enzyme>>BH3I-1

BH3I-1 (Synonyms: BHI1; BH 3I1)

Catalog No.GC18136

BH3I-1 est un antagoniste de la famille Bcl-2, qui inhibe la liaison du peptide Bak BH3 À Bcl-xL avec un Ki de 2,4 ± 0,2 μM dans le test FP. BH3I-1 a un Kd de 5,3 μM contre le couple p53/MDM2.

Products are for research use only. Not for human use. We do not sell to patients.

BH3I-1 Chemical Structure

Cas No.: 300817-68-9

Taille Prix Stock Qté
2mg
44,00 $US
En stock
5mg
71,00 $US
En stock
10mg
101,00 $US
En stock
25mg
213,00 $US
En stock
50mg
369,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

IC50: 293.95 μM

BH3I-1 is an inhibitor of Bcl-2 or Bcl-XL.

It has been reported that a disregulation of the Bcl-2/ Bcl-XL family proteins may result in the development of cancer, since the failure of the inactivation of pro-apoptotic pathways, or the activation of anti-apoptotic pathways, may occur in the regulation processes.

In vitro: The Bcl-2 inhibitors BH3I-1 and it analog BH3I-2 had been applied as lead compounds to find possible Bcl-2 or Bcl-X(L) inhibitors by using computer-assisted screening of in-house database. The identified compounds were further studied regarding their possible application as a drug. It was found that the induction of apoptosis, which was shown as number of hypodiploid cells, was increased by adding BH3I-1 and it analog BH3I-2 to Bjab Bcl-XL and Bjab neo/mock cells. In addition, the effects of the pro-apoptotic proteins Bax and Bak on the induction of apoptosis via BH3I-1 and it analog BH3I-2 were investigated with a variety of knockout cell lines, and resulted showed that the presence or absence of Bak or Bax has no significant influence on the amount of apoptotic events induced by BH3I-1 and it analog BH3I-2 [1].

In vivo: Currently, there is no animial in vivo data reported.

Clinical trial: Up to now, BH3I-1 is still in the preclinical development stage.

Reference:
[1] Füllbeck M,Gebhardt N,Hossbach J,Daniel PT,Preissner R.  Computer-assisted identification of small-molecule Bcl-2 modulators. Comput Biol Chem.2009 Dec;33(6):451-6.

Avis

Review for BH3I-1

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BH3I-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.